On October 26, the fourth Signal Series event of the new ISPOR virtual series Signal, "Venture Capital Investment: Upstream Decision Making on Value in Healthcare,” took place.
Global healthcare investment rose for the seventh consecutive quarter, with digital health funding by the end of Q2’21 in the US surpassing the 2020’s record breaking total funding. With megadeals and public exit activity ballooning, is digital health becoming a mainstream market for investment? Where and how is value in healthcare currently identified in the upstream decision-making phase, i.e., by venture capital investment providers and recipients? How much of everything that gets funded in the healthcare space actually addresses and solves the long-standing, systemic pain points in healthcare?
Tom Cassels, Alyssa Jaffee, and Vineeta Agarwala- seasoned venture capital investors with backgrounds from the healthcare settings - discuss the highlights, possible implications and learnings from investment activity for the downstream healthcare decision-making where stakeholders are looking primarily at evidence-based solutions.